V-Bio Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
7
- Investments
-
24
- Portfolio
-
16
- Exits
-
2
V-Bio Ventures General Information
Description
Founded in 2015, V-Bio Ventures is a venture capital firm based in Gent, Belgium. The firm seeks to invest in the therapeutics, diagnostic therapies, and sustainable agriculture sectors based in Europe.
Contact Information
Website
www.v-bio.ventures
Year Founded
2015
Investor Status
Actively Seeking New Investments
Trade Association
Belgian Venturing Association (BVA)
Primary Investor Type
Venture Capital
Other Investor Types
Impact Investing
Primary Office
- Pieter Van Ryesshootlaan 2/104
- Sint-Denijs-Westrem
- 9051 Gent
- Belgium
V-Bio Ventures Investments (24)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AgomAb Therapeutics | 13-Jul-2022 | Early Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | 00000 0000000000 00.0 |
| 00000000 | 16-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000000000 00000 00.0 |
| 00000000 000000000 | 09-Dec-2021 | 0000 00000 | 0000 | Drug Discovery | Startup | 0000 000000 00.0 |
| 000000000 | 02-Sep-2021 | 0000 00000 | 00.00 | Other Agriculture | Generating Revenue | 000000 000000000 00.0 |
| 00000 000000000000 | 21-Jul-2021 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | 000000 000000000 00.0 |
| 0000 000000000000 | 09-Jul-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 00000.000 | 14-Apr-2021 | 00000 00000 | 000.00 | Biotechnology | Product Development | 000000 000000000 00.0 |
| 000000 000 | 16-Mar-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 0000000000 00.0 |
| Oxular | 01-Mar-2021 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | 000000000 00000 00.0 |
| Animab | 27-Oct-2020 | Seed Round | 000 | Drug Discovery | Startup | 000000 000000000 00.0 |
V-Bio Ventures Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Syndesi Therapeutics | 25-Feb-2022 | Merger/Acquisition | 000 |
| 0000000 | 01-Jan-2022 | 000000000 00000000 |
V-Bio Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
V-Bio Ventures Team (8)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Willem Broekaert Ph.D | Co-Founder & Managing Director | 0 | 0 | 0 | Gent, Belgium |
| Christina Takke Ph.D | Managing Partner & Co-Founder | 00 | 0 | 0 | Gent, Belgium |
| Katja Rosenkranz Ph.D | Partner | 0 | 0 | 0 | Gent, Belgium |
| Ward Capoen Ph.D | Principal | 0 | 0 | 0 | Gent, Belgium |
| Ethan Kuo Ph.D | Analyst | Gent, Belgium |
V-Bio Ventures Co-Investors (76)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| VIB | 8 | 0 |
|
|
|
| PMV | 0 | 0 |
|
|
|
| KU Leuven Research & Development | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 | 0 |
|
|
| Omnes Capital | 0 | 0 |
|
|